317 related articles for article (PubMed ID: 28413194)
1. Dual role of cellular prion protein in normal host and Alzheimer's disease.
Onodera T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(4):155-173. PubMed ID: 28413194
[TBL] [Abstract][Full Text] [Related]
2. Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling.
Ribeiro LW; Pietri M; Ardila-Osorio H; Baudry A; Boudet-Devaud F; Bizingre C; Arellano-Anaya ZE; Haeberlé AM; Gadot N; Boland S; Devineau S; Bailly Y; Kellermann O; Bencsik A; Schneider B
Part Fibre Toxicol; 2022 Jul; 19(1):48. PubMed ID: 35840975
[TBL] [Abstract][Full Text] [Related]
3. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
4. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
[TBL] [Abstract][Full Text] [Related]
5. Loss of STI1-mediated neuronal survival and differentiation in disease-associated mutations of prion protein.
Landemberger MC; de Oliveira GP; Machado CF; Gollob KJ; Martins VR
J Neurochem; 2018 Jun; 145(5):409-416. PubMed ID: 29337365
[TBL] [Abstract][Full Text] [Related]
6. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
[TBL] [Abstract][Full Text] [Related]
7. The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity.
Ostapchenko VG; Beraldo FH; Mohammad AH; Xie YF; Hirata PH; Magalhaes AC; Lamour G; Li H; Maciejewski A; Belrose JC; Teixeira BL; Fahnestock M; Ferreira ST; Cashman NR; Hajj GN; Jackson MF; Choy WY; MacDonald JF; Martins VR; Prado VF; Prado MA
J Neurosci; 2013 Oct; 33(42):16552-64. PubMed ID: 24133259
[TBL] [Abstract][Full Text] [Related]
8. Conditional Deletion of
Salazar SV; Gallardo C; Kaufman AC; Herber CS; Haas LT; Robinson S; Manson JC; Lee MK; Strittmatter SM
J Neurosci; 2017 Sep; 37(38):9207-9221. PubMed ID: 28842420
[TBL] [Abstract][Full Text] [Related]
9. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
[TBL] [Abstract][Full Text] [Related]
11. Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity.
Pagano K; Galante D; D'Arrigo C; Corsaro A; Nizzari M; Florio T; Molinari H; Tomaselli S; Ragona L
Mol Neurobiol; 2019 Mar; 56(3):1957-1971. PubMed ID: 29981054
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
[TBL] [Abstract][Full Text] [Related]
13. Regulation of RhoA activity by the cellular prion protein.
Kim HJ; Choi HS; Park JH; Kim MJ; Lee HG; Petersen RB; Kim YS; Park JB; Choi EK
Cell Death Dis; 2017 Mar; 8(3):e2668. PubMed ID: 28300846
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
[TBL] [Abstract][Full Text] [Related]
15. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
[TBL] [Abstract][Full Text] [Related]
16. PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity.
Mengel D; Hong W; Corbett GT; Liu W; DeSousa A; Solforosi L; Fang C; Frosch MP; Collinge J; Harris DA; Walsh DM
Brain Res; 2019 May; 1710():125-135. PubMed ID: 30593771
[TBL] [Abstract][Full Text] [Related]
17. Prion Protein: The Molecule of Many Forms and Faces.
Kovač V; Čurin Šerbec V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163156
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of neuroprotection against ischemic insult by stress-inducible phosphoprotein-1/prion protein complex.
Beraldo FH; Ostapchenko VG; Xu JZ; Di Guglielmo GM; Fan J; Nicholls PJ; Caron MG; Prado VF; Prado MAM
J Neurochem; 2018 Apr; 145(1):68-79. PubMed ID: 29265373
[TBL] [Abstract][Full Text] [Related]
19. PrP(C) signalling in neurons: from basics to clinical challenges.
Hirsch TZ; Hernandez-Rapp J; Martin-Lannerée S; Launay JM; Mouillet-Richard S
Biochimie; 2014 Sep; 104():2-11. PubMed ID: 24952348
[TBL] [Abstract][Full Text] [Related]
20. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
